Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma.
Khadega A AbuelgasimMohsen AlzahraniYousef AlsharhanMoataz KhairiMohammed HommadyGiamal GmatiHind SalamaOsama AliBader AlahmariEmad M MasuadiAhmed S Al AskarAyman AlhejaziMoussab DamlajPublished in: Bone marrow transplantation (2019)